Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML

El‐Deen, N.A., DeFilippis, R., Abdel‐Aziz, A.K. et al. (15 more authors) (2025) Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML. Archiv der Pharmazie, 358 (5). e70002. ISSN 0365-6233

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • El‐Deen, N.A.
  • DeFilippis, R.
  • Abdel‐Aziz, A.K.
  • Milik, S.N.
  • Patel, S.
  • Ismail, M.I.
  • Khaled, O.
  • Ahmed, T.E.
  • Abdelfattah, A.G.
  • Ali, E.M.H.
  • Gaballah, M.Y.
  • McPhillie, M.J. ORCID logo https://orcid.org/0000-0001-8264-8211
  • Abouzid, K.A.M.
  • Serya, R.A.T.
  • Henary, M.
  • Minucci, S.
  • Shah, N.P.
  • Dokla, E.M.E.
Copyright, Publisher and Additional Information:

This is an author produced version of an article accepted for publication in Archiv der Pharmazie made available under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: acute myeloid leukemia; benzimidazole; kinase inhibitor; molecular dynamics; mutant FLT3
Dates:
  • Accepted: 12 April 2025
  • Published (online): 9 May 2025
  • Published: 9 May 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Engineering & Physical Sciences (Leeds) > School of Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 May 2025 15:31
Last Modified: 22 May 2025 15:31
Status: Published
Publisher: Wiley
Identification Number: 10.1002/ardp.70002
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics